Forty51 Ventures

Forty51 Ventures is a venture capital investment firm based in Basel, Switzerland, founded in 2022. The firm focuses on building and investing in early-stage biotech companies across Europe, with a particular emphasis on Switzerland, France, and Germany. Its primary interest lies in the biotech and life science sectors, reflecting a commitment to fostering innovation in these fields.

1 past transactions

Mosanna Therapeutics

Seed Round in 2022
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.